StockTipsArenaBeta

BUY Jubilant Pharmova Limited — Vishvesh Chauhan, ChaseAlpha

BUYJubilant Pharmova Limited

byVishvesh Chauhan, ChaseAlphaHorizon: NA (inferred Swing (≤2wk))15 Sept 2026via Zee Business (Live)

Entry₹1,040Inferred
Target₹1,200
Total upside +15.38%
Stop loss₹970-6.73% risk
CMP₹1,002.51h ago
Active-3.61%+19.70%upside left 12d left
Follow Vishvesh Chauhan for new callsGet alertsWatch JUBLPHARMA for new buy/sell callsGet alertsSee 121 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 16 Sept, 5:27 pm IST
1 supporting1 neutral3 opposing
Supports the BUY call (1)

MACD above its signal line — bullish momentum

Technicals · macd·16 Sept · today

Neutral / worth noting (1)

Jubilant Pharmova's US CMO facility gets 'Voluntary Action Indicated' classification

NewsCnbc-Tv18·11 Sept · 4d ago

(opens in new tab)
Weighs against the BUY call (3)

RSI at 80 — overbought territory

Technicals · rsi·16 Sept · today

Jubilant Pharmova Gets ₹87.31 Crore GST Notice From Mysore Tax Authorities For FY23

NewsGoogle News·1 Sept · 2w ago

(opens in new tab)

Jubilant Pharmova: ₹87 கோடி GST நோட்டீஸ்! அதிரடியாக மறுப்பு தெரிவித்த நிறுவனம்

NewsGoogle News·1 Sept · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.